TherapeuticsMD, Inc.
Hedge Funds Holdings
Last updated:
TherapeuticsMD, Inc.‘s stocks are currently a part of 25 hedge funds’ portfolios, which represents 20.63% of the total amount of its stocks outstanding. This makes up a total of 1.93M shares of TherapeuticsMD, Inc.. Compared to the previous quarter, the number fell by -44.41% or -1.54M shares fewer. As for the holding position changes, 16% (4) of current hedge fund investors increased the number of shares held, 20% (5) of current holders sold a part of the shares held, and 24% (6) closed the holdings completely. 5 hedge funds are new holders of TherapeuticsMD, Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding TherapeuticsMD (Q2 2018 – Q1 2023)
Q2 2018 | 143 |
---|---|
Q3 2018 | 154 |
Q4 2018 | 137 |
Q1 2019 | 144 |
Q2 2019 | 147 |
Q3 2019 | 149 |
Q4 2019 | 168 |
Q1 2020 | 140 |
Q2 2020 | 147 |
Q3 2020 | 141 |
Q4 2020 | 155 |
Q1 2021 | 158 |
Q2 2021 | 151 |
Q3 2021 | 145 |
Q4 2021 | 122 |
Q1 2022 | 115 |
Q2 2022 | 44 |
Q3 2022 | 31 |
Q4 2022 | 44 |
Q1 2023 | 25 |
Hedge funds changes in TherapeuticsMD positions (Q2 2018 – Q1 2023)
Q2 2018 | 22 | 51 | 44 | 18 | 8 |
---|---|---|---|---|---|
Q3 2018 | 26 | 59 | 32 | 14 | 23 |
Q4 2018 | 20 | 47 | 44 | 35 | -9 |
Q1 2019 | 26 | 58 | 31 | 20 | 9 |
Q2 2019 | 24 | 59 | 28 | 17 | 19 |
Q3 2019 | 23 | 46 | 39 | 20 | 21 |
Q4 2019 | 32 | 57 | 39 | 13 | 27 |
Q1 2020 | 10 | 40 | 52 | 35 | 3 |
Q2 2020 | 25 | 46 | 37 | 18 | 21 |
Q3 2020 | 16 | 31 | 48 | 22 | 24 |
Q4 2020 | 27 | 45 | 39 | 14 | 30 |
Q1 2021 | 28 | 61 | 26 | 23 | 20 |
Q2 2021 | 15 | 50 | 38 | 23 | 25 |
Q3 2021 | 19 | 50 | 34 | 23 | 19 |
Q4 2021 | 14 | 32 | 49 | 36 | -9 |
Q1 2022 | 15 | 23 | 41 | 21 | 15 |
Q2 2022 | 42 | 0 | 2 | 113 | -113 |
Q3 2022 | 7 | 8 | 10 | 20 | -14 |
Q4 2022 | 19 | 10 | 7 | 5 | 3 |
Q1 2023 | 5 | 4 | 5 | 6 | 5 |
Hedge funds changes in TherapeuticsMD stock options (Q2 2018 – Q1 2023)
Q2 2018 | 7,212,000 | 3,943,000 |
---|---|---|
Q3 2018 | 7,416,000 | 5,800,000 |
Q4 2018 | 1,922,000 | 1,668,000 |
Q1 2019 | 2,546,000 | 2,773,000 |
Q2 2019 | 2,990,000 | 5,772,000 |
Q3 2019 | 4,872,000 | 5,694,000 |
Q4 2019 | 3,331,000 | 2,399,000 |
Q1 2020 | 796,000 | 669,000 |
Q2 2020 | 847,000 | 1,056,000 |
Q3 2020 | 1,939,000 | 1,568,000 |
Q4 2020 | 1,168,000 | 1,267,000 |
Q1 2021 | 2,555,000 | 1,540,000 |
Q2 2021 | 2,012,000 | 865,000 |
Q3 2021 | 1,095,000 | 558,000 |
Q4 2021 | 438,000 | 208,000 |
Q1 2022 | 183,000 | 93,000 |
Q2 2022 | 4,215,000 | 5,611,000 |
Q3 2022 | 2,274,000 | 3,397,000 |
Q4 2022 | 1,602,670 | 2,858,851 |
Q1 2023 | 241,204,000 | 243,759,000 |